Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]

Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]

<p>Abstract</p> <p>Background</p> <p>Activation of inflammatory pathways plays an important contributory role in coronary plaque instability and subsequent rupture, which can lead to the development of acute coronary syndrome (ACS). Elevated levels of serum inflammatory...

Full description

Bibliographic Details
Main Authors: Slaby Josef, Nemecek Eduard, Aschermann Ondrej, Wiendl Martin, Kettner Jiri, Kvapil Milan, Veselka Josef, Blasko Peter, Mates Martin, Vejvoda Jiri, Hajek Petr, Alan David, Ostadal Petr, Holm Frantisek, Rac Marek, Macek Milan, Cepova Jana
Format: Article
Language:English
Published: BMC 2005-03-01
Series:Current Controlled Trials in Cardiovascular Medicine
Subjects:
statin
fluvastatin
acute coronary syndrome
C-reactive protein
interleukin 6
pregnancy-associated plasma protein A
Online Access:http://cvm.controlled-trials.com/content/6/1/4

Internet

http://cvm.controlled-trials.com/content/6/1/4

Similar Items